Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED180 Life Sciences Corp. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
180 Life Sciences Corp. Earnings Date And Information
180 Life Sciences Corp. last posted its earnings results on Monday, March 25th, 2024. The company reported $-1.97012 earnings per share for the quarter, topping analysts' consensus estimates of $-22.8 by $20.82988. The company had revenue of 0 for the quarter and had revenue of 0 for the year. 180 Life Sciences Corp. has generated $-53 earnings per share over the last year ($-52.59 diluted earnings per share) and currently has a price-to-earnings ratio of -0.37. 180 Life Sciences Corp. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 20th, 2025 based on prior year's report dates.
180 Life Sciences Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | N/A | -$0.85 | N/A | $0 | $0 |
| 08/12/2024 | Q2 2024 | N/A | $0.01 | N/A | $0 | $0 |
| 05/15/2024 | Q1 2024 | N/A | -$1.68 | N/A | N/A | $0 |
| 04/29/2024 | Q4 2023 | N/A | -$1.97 | N/A | N/A | $166,030 |
| 11/09/2023 | Q3 2023 | -$26.60 | -$24.56 | 2.04 | N/A | $0 |
| 08/15/2023 | Q2 2023 | -$26.60 | -$13.38 | 13.22 | N/A | $0 |
| 05/15/2023 | Q1 2023 | -$38.00 | -$24.17 | 13.83 | N/A | $0 |
| 04/28/2023 | Q4 2022 | N/A | -$185.83 | N/A | N/A | $0 |
| 11/10/2022 | Q3 2022 | $0.20 | -$208.61 | -208.81 | N/A | $0 |
| 08/09/2022 | Q2 2022 | -$2.60 | $32.74 | 35.34 | N/A | $0 |
| 05/16/2022 | Q1 2022 | N/A | $17.45 | N/A | N/A | $0 |
| 03/30/2022 | Q4 2021 | -$2.60 | $11.60 | 14.2 | N/A | $0 |
| 11/12/2021 | Q3 2021 | N/A | $212.44 | N/A | N/A | $0 |
| 08/16/2021 | Q2 2021 | N/A | -$286.09 | N/A | N/A | $0 |
| 07/16/2021 | Q1 2021 | N/A | -$221.90 | N/A | N/A | $0 |
| 07/09/2021 | Q4 2020 | N/A | -$156.27 | N/A | N/A | $0 |
| 11/23/2020 | Q3 2020 | N/A | -$18.85 | N/A | N/A | $0 |
| 08/19/2020 | Q2 2020 | N/A | $6.03 | N/A | N/A | $0 |
| 05/22/2020 | Q1 2020 | N/A | -$54.12 | N/A | N/A | $0 |
| 04/07/2020 | Q4 2019 | N/A | -$308.35 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
180 Life Sciences Corp. Earnings: FAQ's
180 Life Sciences Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 20th, 2025 based offlast year's report dates.
In the previous quarter, 180 Life Sciences Corp. (:ATNF) reported $-1.97012 earnings per share (EPS) to beat the analysts' consensus estimate of $-22.8 by $20.82988.
The conference call for 180 Life Sciences Corp.'s latest earnings report can be listened to online.
The conference call transcript for 180 Life Sciences Corp.'s latest earnings report can be read online.
180 Life Sciences Corp. (:ATNF) has a recorded net income of $-19,935,112.180 Life Sciences Corp. has generated $-52.6 earnings per share over the last four quarters.
180 Life Sciences Corp. (:ATNF) has a price-to-earnings ratio of -0.37 and price/earnings-to-growth ratio is -0.